Kd. Croen, EVIDENCE FOR AN ANTIVIRAL EFFECT OF NITRIC-OXIDE - INHIBITION OF HERPES-SIMPLEX VIRUS TYPE-1 REPLICATION, The Journal of clinical investigation, 91(6), 1993, pp. 2446-2452
Nitric oxide (NO) has antimicrobial activity against a wide spectrum o
f infectious pathogens, but an antiviral effect has not been reported.
The impact of NO, from endogenous and exogenous sources, on herpes si
mplex virus type 1 (HSV 1) replication was studied in vitro. HSV 1 rep
lication in RAW 264.7 macrophages was reduced 1,806-fold in monolayers
induced to make NO by activation with gammaIFN and LPS. A competitive
and a noncompetitive inhibitor of nitric oxide synthetase substantial
ly reduced the antiviral effect of activated RAW macrophages. S-nitros
o-L-acetyl penicillamine (SNAP) is a donor of NO and was added to the
media of infected monolayers to assess the antiviral properties of NO
in the absence of gammaIFN and LPS. A single dose of S-nitroso-L-acety
l penicillamine 3 h after infection inhibited HSV 1 replication in Ver
o, HEp2, and RAW 264.7 cells in a dose-dependent manner. Neither viruc
idal nor cytocidal effects of NO were observed under conditions that i
nhibited HSV 1 replication. Nitric oxide had inhibitory effects, compa
rable to that of gammaIFN/LPS, on protein and DNA synthesis as well as
on cell replication. This report demonstrates that, among its diverse
properties, NO has an antiviral effect.